Risk Factors, Patterns, and Long-Term Survival of Recurrence After Radiofrequency Ablation With or Without Transarterial Chemoembolization for Hepatocellular Carcinoma
ObjectivesTo classify hepatocellular carcinoma (HCC) recurrence patterns after radiofrequency ablation (RFA) or transarterial chemoembolization (TACE) combined with RFA (TACE-RFA) and analyze their risk factors and impacts on survival.MethodsWe retrospectively evaluated the medical records of HCC pa...
Main Authors: | Jingjun Huang, Wensou Huang, Yongjian Guo, Mingyue Cai, Jingwen Zhou, Liteng Lin, Kangshun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.638428/full |
Similar Items
-
Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01) -
Gallbladder actinomycosis: Is it a complication after radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma?
by: Han Hyung, et al.
Published: (2011-06-01) -
Feeding artery ablation before radiofrequency ablation for hepatocellular carcinoma may reduce critical recurrence
by: Ryo Shimizu, et al.
Published: (2021-04-01) -
Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
by: Tae Wook Kang, et al.
Published: (2017-03-01) -
Transarterial chemoembolization combined with iodine 125 seeds versus transarterial chemoembolization combined with radiofrequency ablation in the treatment of early- and intermediate-stage hepatocellular carcinoma
by: Lei Chen, et al.
Published: (2020-06-01)